Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:15 PM
Ignite Modification Date:
2025-12-25 @ 12:24 PM
NCT ID:
NCT00404495
Group ID:
EG001
Title:
Temozolomide + Irinotecan for High-Grade Glioma
Description:
For participants with high-grade glioma: Irinotecan 10 mg/m\^2/day on Days 1-5 and Days 8-12 in repeated 3-week cycles. Temozolomide 100-125 mg/m\^2 daily on Days 1-5 in repeated 3-week cycles; treatment duration: 2 cycles as a window phase before starting standard therapy.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
17
Other Number Affected:
17
Other Number At Risk:
17
Study:
NCT00404495
Results Section:
NCT00404495
Adverse Events Module:
NCT00404495